Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by G. Didoni
PMS12 a Budget Impact Model for the Use of Abatacept as a First Biologic Treatment for Rheumatoid Arthritis in Italy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Pms21 - Budget Impact Model of Inclusion of Tofacitinib for the Treatment of Rheumatoid Arthritis in France
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Abatacept: A T-Cell Co-Stimulation Modulator for the Treatment of Rheumatoid Arthritis
Clinical Rheumatology
Medicine
Rheumatology
Abatacept: The Evidence for Its Place in the Treatment of Rheumatoid Arthritis
Core Evidence
Medicine
Reviews
References
Pharmacology
Biologic Treatments for Rheumatoid Arthritis
Trends in Urology & Men's Health
Persistence With Biologic Agents for the Treatment of Rheumatoid Arthritis in Japan
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
Indirect Treatment Comparison of Abatacept With Methotrexate Versus Other Biologic Agents for Active Rheumatoid Arthritis Despite Methotrexate Therapy in the United Kingdom
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Reasons for Discontinuation of Subcutaneous Biologic Therapy in the Treatment of Rheumatoid Arthritis: A Patient Perspective
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
SAT0081 Relationship Between Rheumatoid Factor Positivity and Treatment Effect With a First Biologic Agent in Rheumatoid Arthritis: Multicenter Study Using a Mixed-Effect Model
Impact of Price Regulation of Biologic Therapies for Rheumatoid Arthritis in Colombia – A Cost Minimization Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental